Company Long-Term Loans and Borrowings: intracellulartherapies.com (ITCI)
Intra-Cellular Therapies (ITCI) focuses on developing schizophrenia therapies, where certified developments are becoming the benchmark treatment for patients with chronic diagnoses. This daily price chart reflects the 0.01 indicator. Growth is driven by the success of Caplyta in treating depressive disorders, while the strategy to scale antipsychotics in the US through an expanded sales network and new indications guarantees long-term success.
Intra-Cellular Therapies, Inc. - analytical breakdowns and key metrics (ITCI)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Debt to Equity Ratio Intra-Cellular Therapies|ITCI - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Intra-Cellular Therapies Inc.|ITCI - Company Debts|Debt to Net Assets Ratio Intra-Cellular Therapies|ITCI - Company Long-Term Debts|Company Short-Term Debts Intra-Cellular Therapies|Critical Liquidity intracellulartherapies.com
- earnings and market multiples details:
Analysis of all company metrics:Intra-Cellular Therapies
Developing schizophrenia drugs entails colossal risks and stringent regulatory pressure. Under these conditions, the long-term debt dynamics of Intra-Cellular Therapies (ITCI) reflect the volume of credit obligations with maturities exceeding one year. A decrease in this metric indicates a healthier balance sheet, yet excessive deleveraging activity may limit the capital available for clinical trials. It is critical for investors to find a balance between financial stability and the resources necessary to compete with pharma behemoths.
Who Intra-Cellular Therapies competes with
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|vikingtherapeutics.com (VKTX) - Long-Term Debt Volume|Company Long-Term Debt Supernus (SUPN)|Catalyst Pharma - Company Long-Term Indebtedness|Denali Therapeutics Inc - Company Long-Term Liabilities|Amount of Long-Term Liabilities HRMY (Harmony Corp)|BHVN - Company Long-Term Debt|Company Long-Term Loans and Borrowings AMLX (amylyx.com)|TRVI: Company Long-Term Debts|Praxis Precision Medicines Inc (PRAX) - Company Long-Term Debts|Company Long-Term Liabilities AVXL|CBLL - Long-Term Indebtedness|Company Long-Term Debts PRTA|Company Long-Term Liabilities alector.com ALEC|Company Long-Term Debts ANNX (Annexon)|Omeros Corp (OMER) - Long-Term Debt|NGNE - Company Long-Term Debt|ACIU: Company Long-Term Debt|Voyager Therapeutics (VYGR) - Company Long-Term Debt|NMRA (neumoratx.com) - Company Long-Term Debt|Company Long-Term Liabilities SCLX|Company Long-Term Debts Tevogen Bio Holdings Inc.|Company Long-Term Debt Alpha Cognition (ACOG)|Company Long-Term Debt CGTX (cogrx.com)|Company Long-Term Debts IKT (Inhibikase Therapeutics)|Company Long-Term Debts cassavasciences.com SAVA|ASRT - Company Long-Term Debt|Company Long-Term Loans and Borrowings COYA (Coya Therapeutics, Inc.)|VTGN (vistagen.com) - Company Long-Term Liabilities|Ovid Therapeutics - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities ABOS|CRVO (cervomed.com) - Amount of Long-Term Liabilities|Company Long-Term Debts ATHE|CLNN (clene.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts PEPG (PepGen)|jupiterneurosciences.com (JUNS) - Long-Term Debt|RLMD - Company Long-Term Debt|Company Long-Term Loans and Borrowings ANVS (annovisbio.com)|GRCE: Company Long-Term Debts|Firefly Neuroscience, Inc. (AIFF) - Company Long-Term Debts|Company Long-Term Debt ANEW Medical|NeuroSense Therapeutics, Ltd. - Long-Term Liabilities|Company Long-Term Debts RVPH|Long-Term Debt Volume metaviatx.com|Company Long-Term Debts NRXS (NeurAxis)|Helius Medical Technologies, Inc. (HSDT) - Long-Term Debt|PASG - Company Long-Term Debt|Long-Term Debt Volume Neuphoria Therapeutics Inc. NEUP|NERV: Company Long-Term Debts|ATHA - Long-Term Debt Volume|Company Long-Term Liabilities ADXN|ALZN (Alzamend) - Amount of Long-Term Liabilities|Company Long-Term Debts CYCN|Company Long-Term Liabilities protagenic.com PTIX|Company Long-Term Debts KTTA (Pasithea Therapeutics Corp.)|Long-Term Debt Volume Cortigent Inc (CRGT)|ATXI - Company Long-Term Debt|BCLI (Brainstorm Cell Therapeutics Inc.) - Company Long-Term Indebtedness|CARA: Company Long-Term Debts|Long-Term Debt Chromocell (CHRO)|Company Long-Term Liabilities ELYM|Company Long-Term Debts longboardpharma.com|Company Long-Term Debt Marinus Pharmaceuticals, Inc. (MRNS)|NKGN (NKGen Biotech Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debt NeuroBo NRBO|Sage Therapeutics Inc (SAGE) - Long-Term Debt|Synaptogenix, Inc. - Company Long-Term Debts|Long-Term Debt Volume trevena.com TRVN|vigilneuro.com (VIGL) - Company Long-Term Debt|Company Long-Term Indebtedness WENA|Company Long-Term Liabilities CERE